nicardipine has been researched along with Phlebitis in 3 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Phlebitis: Inflammation of a vein, often a vein in the leg. Phlebitis associated with a blood clot is called (THROMBOPHLEBITIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effect of two concentrations of intravenous administration of nicardipine hydrochloride on nicardipine-related phlebitis in patients with preeclampsia." | 8.12 | Clinical efficacy and safety of two concentrations of intravenous nicardipine hydrochloride for nicardipine-related phlebitis in patients with preeclampsia. ( Kong, B; Li, Y; Lu, Q; Ye, F, 2022) |
| "Nicardipine is frequently used in the treatment of hypertension for patients with acute stroke; however, its dosing is complicated by a high risk of phlebitis." | 7.88 | Reduction of Nicardipine-Related Phlebitis in Patients with Acute Stroke by Diluting Its Concentration. ( Kawada, K; Miyamoto, N; Ohta, T; Tanaka, K, 2018) |
| "Intravenous nicardipine is generally used to treat hypertension in acute stroke patients but is associated with frequent phlebitis." | 7.83 | Risk Factors of Nicardipine-Related Phlebitis in Acute Stroke Patients. ( Kadoguchi, N; Kawada, K; Morimoto, M; Ohta, T; Tanaka, K; Yamamoto, S, 2016) |
| "To evaluate the effect of two concentrations of intravenous administration of nicardipine hydrochloride on nicardipine-related phlebitis in patients with preeclampsia." | 4.12 | Clinical efficacy and safety of two concentrations of intravenous nicardipine hydrochloride for nicardipine-related phlebitis in patients with preeclampsia. ( Kong, B; Li, Y; Lu, Q; Ye, F, 2022) |
| "Nicardipine is frequently used in the treatment of hypertension for patients with acute stroke; however, its dosing is complicated by a high risk of phlebitis." | 3.88 | Reduction of Nicardipine-Related Phlebitis in Patients with Acute Stroke by Diluting Its Concentration. ( Kawada, K; Miyamoto, N; Ohta, T; Tanaka, K, 2018) |
| "Intravenous nicardipine is generally used to treat hypertension in acute stroke patients but is associated with frequent phlebitis." | 3.83 | Risk Factors of Nicardipine-Related Phlebitis in Acute Stroke Patients. ( Kadoguchi, N; Kawada, K; Morimoto, M; Ohta, T; Tanaka, K; Yamamoto, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ye, F | 1 |
| Lu, Q | 1 |
| Kong, B | 1 |
| Li, Y | 1 |
| Kawada, K | 2 |
| Ohta, T | 2 |
| Tanaka, K | 2 |
| Miyamoto, N | 1 |
| Kadoguchi, N | 1 |
| Yamamoto, S | 1 |
| Morimoto, M | 1 |
3 other studies available for nicardipine and Phlebitis
| Article | Year |
|---|---|
Clinical efficacy and safety of two concentrations of intravenous nicardipine hydrochloride for nicardipine-related phlebitis in patients with preeclampsia.
Topics: Administration, Intravenous; Humans; Infusions, Intravenous; Nicardipine; Phlebitis; Pre-Eclampsia; | 2022 |
Reduction of Nicardipine-Related Phlebitis in Patients with Acute Stroke by Diluting Its Concentration.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antihypertensive Agents; Female; Humans; Hyper | 2018 |
Risk Factors of Nicardipine-Related Phlebitis in Acute Stroke Patients.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antihypertensive Agents; Dose-Response Relatio | 2016 |